Overview
International law firm McDermott Will & Emery represented Ampersand Capital Partners, a heathcare-focused private equity firm, in the sale of its portfolio company Adaptas Solutions, a manufacturer of mass spectrometry subsystems and components, to IMI plc, a UK-based engineering specialist.
- The transaction was announced on November 15, 2021.
- McDermott acted as legal counsel to Ampersand Capital Partners.
- Adaptas Solutions will become part of IMI’s Precision Fluid OEM Business Unit within IMI Precision Engineering.
- The McDermott team was led by Kristian Werling and Hunter Sharp and included John Zukin, Jordan Wampler, Alex Ruiz, Emily Mussio, James Ross, David Henry, David Levine, David Neville, Noah Feldman-Greene, Karolien Van der Putten, Jeff Holdvogt, Nick Paul, Jed Gordon, Connor Romm, Mark Bilut, Brian Mead and Anh Lee.
- Read IMI’s release here.
McDermott’s private equity practice is among the top four most active PE law firms globally and in the US with more than 160 dedicated private equity lawyers in 21 locations globally. In addition to being Pitchbook’s top Healthcare PE firm for a fourth consecutive year and fifth in both IT and financial services private equity, we are named Energy & Industrials Law Firm of the Year (Large Cap) by The Deal, Top 10 in PE Buyouts by MergerMarket and Top 10 in US Mid-Market by Bloomberg. Learn more about our PE practice by visiting mwe.com/pe.
About McDermott
McDermott Will & Emery partners with leaders around the world to fuel missions, knock down barriers and shape markets. Our team works seamlessly across practices, industries and more than 20 locations to deliver highly effective—and often unexpected—solutions that propel success. More than 1,200 lawyers strong, we bring our personal passion and legal prowess to bear in every matter for our clients and the people they serve.
